©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 110736
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.110736
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.110736
Figure 1 Expression and subcellular localization of transient receptor potential melastatin 6 and transient receptor potential melastatin 7 in parental and spheroid-derived HT-29 cells.
A: The western blot analysis of transient receptor potential melastatin (TRPM) 6; B: The western blot analysis of TRPM7; C: TRPM6 in immunoprecipitation of TRPM6 (IP-TRPM6); D: TRPM7 in IP-TRPM6 of parental HT-29 monolayers and spheroid-derived cells; E: The densitometric analysis of TRPM6; F: The densitometric analysis of TRPM7; G: TRPM6 in IP-TRPM6; H: TRPM7 in IP-TRPM6 of parental HT-29 monolayers and spheroid-derived cells. Total: Total cell; Cyto: Cytosol; Mem: Membrane; SP: Spheroid; TRPM: Transient receptor potential melastatin; IP-TRPM6: Immu noprecipitation of transient receptor potential melastatin 6. aP < 0.05, bP < 0.01, cP < 0.01 vs the corresponding parental cells (n = 6).
- Citation: Kampuang N, Chamniansawat S, Pongkorpsakol P, Treveeravoot S, Thongon N. Transient receptor potential melastatin 6 and transient receptor potential melastatin 6/7 antagonists suppress colon adenocarcinoma HT-29 cells. World J Gastrointest Oncol 2025; 17(12): 110736
- URL: https://www.wjgnet.com/1948-5204/full/v17/i12/110736.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i12.110736